These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 813573)

  • 41. In vitro evaluation of Ro 13-9904.
    Hinkle AM; Bodey GP
    Antimicrob Agents Chemother; 1980 Oct; 18(4):574-8. PubMed ID: 6778383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibacterial activity of cefpodoxime in vitro.
    Liu YC; Huang WK; Cheng DL
    Chemotherapy; 1997; 43(1):21-6. PubMed ID: 8996737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Computerized analysis of activity profiles of beta-lactams].
    Pitton JS; Philippin JL; Fournier P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):581-5. PubMed ID: 3937131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of cefdinir (FK 482, PD 134393, CI-983): a new orally active cephalosporin.
    Qadri SM; Ueno Y; Saldin H; Cunha BA
    Chemotherapy; 1993; 39(2):112-9. PubMed ID: 8458243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative in-vitro activity and mode of action of ceftriaxone (Ro 13-9904), a new highly potent cephalosporin.
    Hall MJ; Westmacott D; Wong-Kai-In P
    J Antimicrob Chemother; 1981 Sep; 8(3):193-203. PubMed ID: 6270051
    [No Abstract]   [Full Text] [Related]  

  • 46. In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae.
    Klein O; Chin NX; Huang HB; Neu HC
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2896-901. PubMed ID: 7695279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CP6679, a new injectable cephalosporin with broad spectrum and potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Ida T; Tsushima M; Ishii T; Atsumi K; Tamura A
    J Infect Chemother; 2002 Jun; 8(2):138-44. PubMed ID: 12111566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam.
    Dudley MN; Ambrose PG; Bhavnani SM; Craig WA; Ferraro MJ; Jones RN;
    Clin Infect Dis; 2013 May; 56(9):1301-9. PubMed ID: 23334813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Synthesis and structure-activity relationships.
    Yoshizawa H; Itani H; Ishikura K; Irie T; Yokoo K; Kubota T; Minami K; Iwaki T; Miwa H; Nishitani Y
    J Antibiot (Tokyo); 2002 Nov; 55(11):975-92. PubMed ID: 12546419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics.
    Jones RN; Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH
    Am J Clin Pathol; 1979 Oct; 72(4):578-85. PubMed ID: 495560
    [No Abstract]   [Full Text] [Related]  

  • 51. In vitro activity of HR 810, a new broad-spectrum cephalosporin.
    Machka K; Braveny I
    Eur J Clin Microbiol; 1983 Aug; 2(4):345-9. PubMed ID: 6313358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of moxalactam and gentamicin: in-vitro study with strains of Staphylococcus aureus and Pseudomonas aeruginosa.
    Skalova R; Hajsig D; Smerdel S
    J Antimicrob Chemother; 1982 Feb; 9(2):103-9. PubMed ID: 6460731
    [No Abstract]   [Full Text] [Related]  

  • 53. In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
    Masuyoshi S; Arai S; Miyamoto M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jul; 18(1):1-8. PubMed ID: 6251749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The in vitro activity of netilmicin against 357 clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus.
    Digranes A; Dibb WL; Ostervold B
    Scand J Infect Dis Suppl; 1980; Suppl 23():30-3. PubMed ID: 6782655
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro activity of DQ-2556, a new cephalosporin.
    Fujimoto T; Otani T; Nakajima R; Une T; Osada Y
    Antimicrob Agents Chemother; 1986 Oct; 30(4):611-3. PubMed ID: 3539013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative antibacterial activity of an arylglycyl oral cephalosporin, LY164846.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1986 Apr; 29(4):703-6. PubMed ID: 3486632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro.
    Hamilton-Miller JM; Brumfitt W; Reynolds AV
    J Antimicrob Chemother; 1978 Sep; 4(5):437-44. PubMed ID: 308505
    [No Abstract]   [Full Text] [Related]  

  • 58. [Enoxacin and ciprofloxacin: in vitro effect on Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus].
    Roy C; Foz A; Segura C; Tirado M; Teixell M; Teruel D
    Med Clin (Barc); 1986 Jan; 86(1):1-3. PubMed ID: 2937983
    [No Abstract]   [Full Text] [Related]  

  • 59. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cefatrizine (SK&F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration--comparative study with cephalexin and cefazolin.
    Actor P; Pitkin DH; Lucyszyn G; Weisbach JA; Bran JL
    Antimicrob Agents Chemother; 1976 May; 9(5):800-3. PubMed ID: 949177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.